Siren Care, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Siren Care, Inc. - overview
Established
2016
Location
San Francisco, CA, US
Primary Industry
Healthcare IT
About
Siren Care, Inc. is a US-based manufacturer specializing in innovative diabetic care solutions that includes smart socks for continuous temperature monitoring to prevent foot ulcers in individuals with diabetes. Siren Care, Inc. develops advanced healthcare products aimed at preventing diabetic foot complications.
Founded in 2016 and headquartered in San Francisco, US, the company has raised a total of USD 9. 5 mn through a Series B funding round in January 2025, led by Mölnlycke Health Care AB. The company's founding team includes Diego Vitale, Henk Scholten, Jie Fu, and CEO Ran Ma. The latest deal marks significant progress in their funding journey, with a total of 7 deals recorded.
Siren Care offers Siren Socks, specially designed to protect diabetes patients from foot ulcers through continuous temperature monitoring. These socks provide real-time data that can indicate potential injuries or inflammation, reducing ulcer risks for over 30% of individuals with diabetes. The product is crucial for patients requiring diligent foot care management and is marketed primarily to individuals with diabetes and healthcare providers. Siren Care generates revenue through a subscription model, where clients receive both the Siren Socks and associated monitoring services.
Healthcare providers, such as nurses and podiatrists, play an essential role in utilizing the sock data to monitor patient health. The business model supports direct-to-consumer sales, allowing patients to access the socks and ongoing health monitoring directly. Costs are covered by Medicare, ensuring affordable long-term care solutions for patients at risk of diabetic foot ulcers. In January 2025, Siren Care, Inc.
raised USD 9. 5 mn in Series B funding, which will be utilized to enhance and develop its healthcare platform. The company is focused on expanding its product offerings and aims to enter new geographic markets, although specific regions have not been disclosed. Upcoming product launches are anticipated to broaden their impact on diabetic care.
Current Investors
Plug and Play, A-Level Capital, DCM
Primary Industry
Healthcare IT
Sub Industries
Footwear, Healthcare IT, Monitoring Equipment, Textiles
Website
www.siren.care
Verticals
Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.